Neurotoxicity in patients with schizophrenia during lithium therapy.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium / Q000009:adverse effects*; D016651:Lithium Carbonate; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced*; D012559:Schizophrenia / Q000188:drug therapy*; D014202:Tremor / Q000139:chemically induced
D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D008094:Lithium